CORRECTION article

Front. Neurol., 22 December 2023

Sec. Multiple Sclerosis and Neuroimmunology

Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1350223

Corrigendum: Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis

  • 1. Institute of Surface Analysis and Chemical Biology, The University of Jinan, Jinan, Shangdong, China

  • 2. Department of Neurology, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Neuroimmunology, Jinan, Shandong, China

In the published article, there was an error in the order of Affiliations. Instead of “1Department of Neurology, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Neuroimmunology, Jinan, Shandong, China. 2Institute of Surface Analysis and Chemical Biology, The University of Jinan, Jinan, Shangdong, China”, it should be “1Institute of Surface Analysis and Chemical Biology, The University of Jinan, Jinan, Shangdong, China. 2Department of Neurology, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Neuroimmunology, Jinan, Shandong, China”.

In the published article, there was an error in the Funding statement. The Funding number was incorrect. The statement was incorrectly written as “The authors would like to thank the financial support from the Natural Science Foundation of China (Nos. 21906065 and 82001825), Natural Science Foundation of Shandong Province (ZR2020QH113), and the Shandong Provincial Grant for the Talent-Leading Teams.” The correct Funding statement appears below.

The authors would like to thank the financial support from the Natural Science Foundation of China (Nos. 21906065 and 82001285), Natural Science Foundation of Shandong Province (ZR2020QH113) and the Shandong Provincial Grant for the Talent-Leading Teams.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Parkinson's disease, multiple sclerosis, natural products, neuroinflammation, oxidative stress, cellular process

Citation

Xu X, Han C, Wang P and Zhou F (2023) Corrigendum: Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis. Front. Neurol. 14:1350223. doi: 10.3389/fneur.2023.1350223

Received

05 December 2023

Accepted

12 December 2023

Published

22 December 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2023

Updates

Copyright

*Correspondence: Pengcheng Wang Feimeng Zhou

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics